Sign In

Login

Password

Forgot Password ? Sign Up

Examorelin (Vietnamese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Examorelin" in Vietnamese language version.

refsWebsite
Global rank Vietnamese rank
19doi.org
2nd place
2nd place
6nih.gov
4th place
7th place
4books.google.com
3rd place
6th place
3archive.org
6th place
4th place

archive.org

books.google.com

doi.org

  • Ghigo E, Arvat E, Gianotti L, Imbimbo BP, Lenaerts V, Deghenghi R, và đồng nghiệp (1994). “Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man”. J Clin Endocrinol Metab. 78 (3): 693–8. doi:10.1210/jcem.78.3.8126144. PMID 8126144.
  • Imbimbo, B.P.; Mant, T.; Edwards, M.; Amin, D.; Dalton, N.; Boutignon, F.; Lenaerts, V.; Wďż˝thrich, P.; Deghenghi, R. (1994). “Growth hormone-releasing activity of hexarelin in humans”. Eur J Clin Pharmacol. 46 (5). doi:10.1007/bf00191904.
  • Moulin A, Ryan J, Martinez J, Fehrentz JA (2007). “Recent developments in ghrelin receptor ligands”. ChemMedChem. 2 (9): 1242–59. doi:10.1002/cmdc.200700015. PMID 17520591.
  • Wang Y, Tomlinson B (2009). “Tesamorelin, a human growth hormone releasing factor analogue”. Expert Opin Investig Drugs. 18 (3): 303–10. doi:10.1517/13543780802707658. PMID 19243281.
  • Carpino, Philip A (2002). “Recent developments in ghrelin receptor (GHS)”. Expert Opin. Ther. Patents. 12 (11): 1599–1618. doi:10.1517/13543776.12.11.1599.
  • Arvat, Emanuela; Vito, Lidia Di; Maccagno, Barbara; Broglio, Fabio; Boghen, Muni F; Deghenghi, Romano; Camanni, Franco; Ghigo, Ezio (1997). “Effects of GHRP”. Peptides. 18 (6): 885–891. doi:10.1016/s0196-9781(97)00016-8.
  • Ghigo, E; Arvat, E; Gianotti, L; Grottoli, S; Rizzi, G; Ceda, G.; Boghen, M.; Deghenghi, R; Camanni, F (1996). “Short-term administration of intranasal or oral Hexarelin, a synthetic hexapeptide, does not desensitize the growth hormone responsiveness in human aging”. European Journal of Endocrinology. 135 (4): 407–412. doi:10.1530/eje.0.1350407.
  • Laron, Z.; Frenkel, J.; Deghenghl, R.; Anin, S.; Klinger, B.; Siibergeld, A. (1995). “Intranasal administration of the GHRP”. Clinical Endocrinology. 43 (5): 631–635. doi:10.1111/j.1365-2265.1995.tb02929.x.
  • Frenkel, J.; Silbergeld, A.; Deghenghi, R.; Laron, Z. (1995). “Short Term Effect of Intranasal Administration of Hexarelin”. Journal of Pediatric Endocrinology and Metabolism. 8 (1). doi:10.1515/jpem.1995.8.1.43.
  • Maccario, M.; Arvat, E.; Procopio, M.; Gianotti, L.; Grottoli, S.; Imbimbo, B.P.; Lenaerts, V.; Deghenghi, R.; Camanni, F. (1995). “Metabolic modulation of the growth hormone-releasing activity of hexarelin in man”. Metabolism. 44 (1): 134–138. doi:10.1016/0026-0495(95)90300-3.
  • Massoud, A F; Hindmarsh, P C; Brook, C G (1996). “Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study”. The Journal of Clinical Endocrinology. 81 (12): 4338–4341. doi:10.1210/jcem.81.12.8954038.
  • Arvat, Emanuela; Vito, Lidia Di; Gianotti, Laura; Ramunni, Josefina; Boghen, Muni F.; Deghenghi, Romano; Camanni, Franco; Ghigo, Ezio (1997). “Mechanisms underlying the negative growth hormone (GH)”. Metabolism. 46 (1): 83–88. doi:10.1016/s0026-0495(97)90173-6.
  • Arvat, Emanuela; Gianotti, Laura; Vito, Lidia Di; Imbimbo, Bruno P.; Lenaerts, Vincent; Deghenghi, Romano; Camanni, Franco; Ghigo, Ezio (1995). “Modulation of Growth Hormone-Releasing Activity of Hexarelin in Man”. Neuroendocrinology. 61 (1): 51–56. doi:10.1159/000126827.
  • Massoud, Ahmed F.; Hindmarsh, Peter C.; Brook, Charles G. D. (1995). “Hexarelin induced growth hormone release is influenced by exogenous growth hormone”. Clinical Endocrinology. 43 (5): 617–621. doi:10.1111/j.1365-2265.1995.tb02927.x.
  • Loche S, Colao A, Cappa M, Bellone J, Aimaretti G, Farello G, và đồng nghiệp (1997). “The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids”. J Clin Endocrinol Metab. 82 (3): 861–4. doi:10.1210/jcem.82.3.3795. PMID 9062497.
  • Loche, S; Cambiaso, P; Carta, D; Setzu, S; Imbimbo, B P; Borrelli, P; Pintor, C; Cappa, M (1995). “The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects”. The Journal of Clinical Endocrinology. 80 (2): 674–678. doi:10.1210/jcem.80.2.7852535.
  • Bellone, J; Aimaretti, G; Bartolotta, E; Benso, L; Imbimbo, B P; Lenhaerts, V; Deghenghi, R; Camanni, F; Ghigo, E (1995). “Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, before and during puberty”. The Journal of Clinical Endocrinology. 80 (4): 1090–1094. doi:10.1210/jcem.80.4.7714074.
  • Rahim A, O'Neill PA, Shalet SM (1998). “Growth hormone status during long-term hexarelin therapy”. J. Clin. Endocrinol. Metab. 83 (5): 1644–9. doi:10.1210/jcem.83.5.4812. PMID 9589671.
  • Suckling K (2006). “Discontinued drugs in 2005: cardiovascular drugs”. Expert Opin Investig Drugs. 15 (11): 1299–308. doi:10.1517/13543784.15.11.1299. PMID 17040192.

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Ghigo E, Arvat E, Gianotti L, Imbimbo BP, Lenaerts V, Deghenghi R, và đồng nghiệp (1994). “Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man”. J Clin Endocrinol Metab. 78 (3): 693–8. doi:10.1210/jcem.78.3.8126144. PMID 8126144.
  • Moulin A, Ryan J, Martinez J, Fehrentz JA (2007). “Recent developments in ghrelin receptor ligands”. ChemMedChem. 2 (9): 1242–59. doi:10.1002/cmdc.200700015. PMID 17520591.
  • Wang Y, Tomlinson B (2009). “Tesamorelin, a human growth hormone releasing factor analogue”. Expert Opin Investig Drugs. 18 (3): 303–10. doi:10.1517/13543780802707658. PMID 19243281.
  • Loche S, Colao A, Cappa M, Bellone J, Aimaretti G, Farello G, và đồng nghiệp (1997). “The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids”. J Clin Endocrinol Metab. 82 (3): 861–4. doi:10.1210/jcem.82.3.3795. PMID 9062497.
  • Rahim A, O'Neill PA, Shalet SM (1998). “Growth hormone status during long-term hexarelin therapy”. J. Clin. Endocrinol. Metab. 83 (5): 1644–9. doi:10.1210/jcem.83.5.4812. PMID 9589671.
  • Suckling K (2006). “Discontinued drugs in 2005: cardiovascular drugs”. Expert Opin Investig Drugs. 15 (11): 1299–308. doi:10.1517/13543784.15.11.1299. PMID 17040192.